HK2 and plasma cell myeloma: The triple combination of HK II’s antisense oligonucleotide, metformin, and pipecillin has exhibited synthetic killing in cultured multiple myeloma cells, while also impeding the progression of HK1-HK II+ multiple myeloma tumors in experimental models [121].